CARDILE, DAVIDE
 Distribuzione geografica
Continente #
EU - Europa 611
NA - Nord America 601
AS - Asia 342
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
SA - Sud America 1
Totale 1.558
Nazione #
US - Stati Uniti d'America 599
IE - Irlanda 191
SE - Svezia 162
CN - Cina 132
VN - Vietnam 98
IT - Italia 95
SG - Singapore 84
DE - Germania 32
FI - Finlandia 31
GB - Regno Unito 24
AT - Austria 23
IN - India 23
PL - Polonia 18
FR - Francia 9
CZ - Repubblica Ceca 8
BE - Belgio 5
UA - Ucraina 4
CH - Svizzera 3
ES - Italia 3
CA - Canada 2
EU - Europa 2
ID - Indonesia 2
IR - Iran 2
CO - Colombia 1
EE - Estonia 1
HK - Hong Kong 1
NL - Olanda 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
Totale 1.558
Città #
Chandler 196
Dublin 189
Nyköping 110
Dong Ket 98
Singapore 70
Beijing 57
Jacksonville 28
Ashburn 27
Princeton 27
Medford 24
Catania 23
Vienna 23
Cambridge 21
Messina 20
Des Moines 19
New York 19
Warsaw 18
Lancaster 17
Dearborn 14
Houston 14
Hyderabad 13
Munich 11
Shenyang 11
Jinan 10
Ann Arbor 8
Boardman 8
Brno 8
Bremen 7
Eboli 7
San Mateo 7
Wilmington 7
Fuzhou 6
Helsinki 6
Taizhou 6
Brussels 5
Hebei 5
Pune 5
Haikou 4
Los Angeles 4
Nanjing 4
Taiyuan 4
Tübingen 4
Waverly Hall 4
Changsha 3
Mislata 3
Norwalk 3
Santa Domenica 3
Temple 3
Barcellona Pozzo di Gotto 2
Comiso 2
Guangzhou 2
Jiaxing 2
Lausanne 2
Leawood 2
Milan 2
Mumbai 2
Ningbo 2
Ragusa 2
Rome 2
Seattle 2
Zhengzhou 2
Ardabil 1
Auckland 1
Bangalore 1
Bogotá 1
Boscobel 1
Brindisi 1
Chaoyang 1
Corbetta 1
Edinburgh 1
Edmonton 1
Fairfield 1
Frankfurt am Main 1
Hangzhou 1
Hanover 1
Hong Kong 1
Jakarta 1
Lannoy 1
Lappeenranta 1
Nanchang 1
Newark 1
Ottawa 1
Pescara 1
Phoenix 1
Redmond 1
Riva 1
San Francisco 1
Shenzhen 1
Stoke-on-Trent 1
Tallinn 1
Tamworth 1
Taunton 1
Tianjin 1
Vittoria 1
Zurich 1
Totale 1.243
Nome #
111In-Pentetreotide in neuroendocrine tumours: comparison between diagnostic scintigraphy and “post-therapy” whole-body scan 102
111In-Pentetreotide for treatment of neuroendocrine tumours: an alternative therapeutic option in particular cases 99
111In-Pentetreotide therapy in patients with inoperable benign intracranial tumors. 93
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 82
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 81
Radiometabolic therapy with 131I for the ablation of the thyroid remnant in patients affected by differentiated thyroid cancer: comparison between four different activities 79
Increased 177Lu-DOTATATE Uptake in Paget Disease 70
BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer 66
A potentially misleading finding at somatostatin receptor scintigraphy: focal pulmonary areas of intense accumulation without computed tomography-detectable lung lesions 65
Peptide Receptor Radionuclide Therapy in Patients with Inoperable Meningiomas: Our Experience and Review of the Literature 65
Peptide receptor imaging in neuroendocrine tumors: comparison between diagnostic scintigraphy and post-therapy whole-body scan 64
Meningocele mimicking a metastasis of papillary thyroid carcinoma 63
Repeated administrations of peptide receptor radionuclide therapy: long term follow-up of renal function. 58
Long term follow-up of renal function in patients who underwent repeated peptide receptor radionuclide therapy 54
Peptide receptor radionuclide therapy in patients with pulmonary neuroendocrine tumors: our experience 53
Demonstration of unknown primitive neuroendocrine tumor by post-treatment imaging with high activities of radiolabeled somatostatin analogues 52
Calibration of a gamma camera for 177Lu quantitative imaging: measurements of sensitivity and scatter correction factors in broad beam geometry 51
Paget disease revealed by Lu-177-DOTATATE post-therapy whole-body scan. 50
Our experience with peptide receptor radionuclide therapy in patients affected by pulmonary neuroendocrine tumors 48
Is Detection of Additional Lesions in Post-Peptide ReceptorRadionuclide Therapy Scans With Respect to DiagnosticImaging Only Due to Different Affinity of Ligands?A Report of Discordance Between Diagnostic and Posttherapy Imaging Using the Same Ligand 46
Differences in the sensitivity of pretherapy and post-therapy scans in patients undergoing peptide receptor radionuclide therapy 41
Usefulness of 111In-pentetreotide therapy in patients with inoperable benign intracranial tumors 40
Post-therapy whole-body scan in patients who underwent peptide receptor radionuclide therapy using 111In-Pentetreotide reveals more lesions than diagnostic imaging with gamma emitters 40
Renal function evaluation in patients undergoing repeated peptide receptor radionuclide therapy 37
null 16
Recombinant human thyrotropin (rhTSH) versus Levo-thyroxine withdrawal in radioiodine therapy of differentiated thyroid cancer patients: differences in abdominal absorbed dose 15
Comparison of 1.1 GBq and 2.2 GBq Activities in Patients with Low-Risk Differentiated Thyroid Cancer Requiring Postoperative 131I Administration: A Real Life Study 13
Febrile Urinary Tract Infections in Children: The Role of High Mobility Group Box-1 12
Role of Nutrition in the Etiopathogenesis and Prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in a Group of Obese Adults 7
Thyroglobulin Value Predict Iodine-123 Imaging Result in Differentiated Thyroid Cancer Patients 7
Cognitive Effects of Transcranial Direct Current Stimulation Plus Robotic Verticalization in Minimally Conscious State 6
Gastroparesis in Adolescent Patient with Type 1 Diabetes: Severe Presentation of a Rare Pediatric Complication 6
Challenges and pitfalls in the management of endocrine toxicities from immune checkpoint inhibitors: a case presentation of synchronous thyrotoxicosis and primary adrenal insufficiency in a melanoma patient 5
What about the Use of Ice Cream as a Supplementary Diet in Chronic Kidney Disease? A Case–Control Study 3
Improving Neuroplasticity through Robotic Verticalization Training in Patients with Minimally Conscious State: A Retrospective Study 1
Totale 1.590
Categoria #
all - tutte 7.266
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.266


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020102 0 0 0 0 0 0 9 12 7 57 13 4
2020/2021213 9 1 36 5 21 7 4 4 3 7 14 102
2021/2022195 2 35 3 7 8 1 18 7 3 33 16 62
2022/2023643 56 74 27 77 51 64 10 37 224 0 16 7
2023/2024160 7 16 9 20 11 47 1 2 1 15 5 26
2024/2025141 13 5 3 50 31 37 2 0 0 0 0 0
Totale 1.590